Bill and Melinda Gates Foundation - mRNA PROPAGANDA [ to end Vaccine hesitancy] for "COVID-19" and "HIV" jabs
Overcoming Vaccine Hesitancy for Future COVID‑19 and HIV Vaccines: Lessons from Measles and HPV Vaccines
Abstract
Background
The discovery of vaccines signifcantly reduced morbidity and mortality of infectious diseases and led to the
elimination and eradication of some. Development of safe and efective vaccines is a critical step to the control of infectious
diseases; however, there is the need to address vaccine hesitancy because of its potential impact on vaccine uptake.
Methods
We conducted a narrative review of studies on interventions to address measles and human papillomavirus vaccine
hesitancy. We discussed how lessons learned from these studies could be applied towards COVID-19 and future human
immunodefciency virus vaccines.
Results
We found that there are several successful approaches to improving vaccine acceptance. Interventions should be
context specifc and build on the challenges highlighted in various settings.
Conclusion
Strategies could be used alone or in combination with others. The most successful interventions directly targeted
the population for vaccination. Use of financial incentives could be a potential tool to improve vaccine uptake
ConclusionLessons for COVID‑19 and Potential HIV Vaccines Review of the studies on improving measles and HPV vaccinations shows that the most promising strategies include use of multi-component interventions especially when education is included. Educational interventions focused on disease risk can be used to improve coverage of COVID-19 and a future HIV vaccine in diverse populations. Message framing is a powerful tool for vaccine promotion; however, messages should be carefully framed and should be targeted to the population of interest. Financial incentives, free-of-charge vaccines, and use of vaccine champions should be considered in future vaccine promotions as they were successful in increasing both measles and HPV vaccine coverage rates. Interventions should be context specific, be designed to target populations, and build on the challenges highlighted in various settings.
Funding
This review was supported by a grant from Bill and Melinda Gates Foundation (GRANT AGREEMENT INVESTMENT ID: INV001288) and Yale Institute for Global Health.
Clearly by financial incentives they are thinking of negative ones!
And as usual...
Conflict of InterestThe authors declare no competing interests.
Comments
Post a Comment